{"product_id":"ultralifecorporation-swot-analysis","title":"Ultralife SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMake Insightful Decisions Backed by Expert Research\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUltralife’s SWOT highlights durable strengths in rugged power solutions and defense contracts, tempered by supply-chain pressures and market concentration; uncover how these factors translate to valuation and risk in the full analysis. Purchase the complete SWOT to access a professionally written, editable report with financial context, strategic recommendations, and an Excel summary—perfect for investors, analysts, and strategists. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDeep Specialization in High-Reliability Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eUltralife focuses on low-volume, high-reliability power for defense and medical markets, where outages are unacceptable, and by end-2025 it held ~18% share of mission-critical lithium primary\/rechargeable segments, per company filings. This niche lets Ultralife charge premiums—avg selling price ~25% above consumer batteries—and deliver stable gross margins near 28% in FY2025. Deep technical certification and long qualification cycles create sticky contracts, reducing churn and insulating revenue from mass-market price wars.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Acquisition of Electrochem Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe late 2024 acquisition of Electrochem Solutions has bolstered Ultralife’s position in energy and industrial markets, especially oil and gas, by adding advanced battery chemistries and IP.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 integration drove strong sales: Battery and Energy Products revenue rose 32.4% in early 2025, contributing to a reported segment revenue uplift of roughly $24.6 million year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRobust Order Backlog and Demand\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eExiting 2025, Ultralife holds a backlog often above 90 million dollars, giving clear revenue visibility and supporting FY26 planning; this reflects steady demand from U.S. and international prime defense contractors and medical device manufacturers, with defense sales growing ~8% year-over-year in 2024–25 and medical orders rising ~12% in 2025; the high-confidence pipeline lets Ultralife smooth manufacturing and capacity despite lumpy government contract timing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Proprietary Battery Technology\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpultralife deep lithium-chemistry engineering yields higher energy density and longer cycle life for niche military medical uses with r spend rising to in fy2024 continued investment through into solid-state ruggedized lines.\u003e\n\u003cpthese proprietary batteries raise entry barriers: small rivals lack scale while larger suppliers focus on generalized products helping ultralife keep premium pricing and defend gross margins margin\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003eR\u0026amp;D $9.8M (FY2024)\u003c\/li\u003e\n\u003cli\u003eGross margin 28.4% (FY2024)\u003c\/li\u003e\n\u003cli\u003eSolid-state pilot programs 2025\u003c\/li\u003e\n\u003cli\u003eFocus: military, medical, industrial niches\u003c\/li\u003e\n\n\u003c\/pthese\u003e\u003c\/pultralife\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeographically Diversified Operational Footprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eUltralife operates manufacturing and sales sites across North America, Europe, and Asia, serving governments and OEMs worldwide and generating roughly 62% of 2024 revenue from international markets (SEC 2024 10-K).\u003c\/p\u003e\n\u003cp\u003eThis global footprint, supported by defense distributors and OEM channels, positions Ultralife to capture Asia‑Pacific backup‑power demand growing ~7% CAGR to 2028 (IHS Markit) and to win regional contracts.\u003c\/p\u003e\n\u003cp\u003eBy end‑2025 the company optimized plants and logistics, reducing tariff exposure and cutting supplier lead times by ~18%, lowering supply‑chain risk.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e62% of 2024 revenue international\u003c\/li\u003e\n\u003cli\u003eAsia‑Pacific backup power ~7% CAGR to 2028\u003c\/li\u003e\n\u003cli\u003eSupply‑chain lead times down ~18% by 2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUltralife: Niche military\/medical batteries, 18% share, 28% margin, \u0026gt;$90M backlog\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eUltralife’s strengths: niche focus on mission‑critical military\/medical batteries with ~18% segment share end‑2025, premium pricing (~25% above consumer) and FY2024 gross margin 28.4%; R\u0026amp;D $9.8M (FY2024) and 2025 solid‑state pilots; Electrochem deal drove 32.4% Battery \u0026amp; Energy sales growth early‑2025 and ~$24.6M uplift; \u0026gt;$90M backlog and 62% international revenue (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSegment share (end‑2025)\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin (FY2024)\u003c\/td\u003e\n\u003ctd\u003e28.4%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D (FY2024)\u003c\/td\u003e\n\u003ctd\u003e$9.8M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBattery sales growth (early‑2025)\u003c\/td\u003e\n\u003ctd\u003e32.4%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBacklog (end‑2025)\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;$90M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInternational rev (2024)\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise SWOT overview of Ultralife, highlighting its core strengths, operational weaknesses, market opportunities, and external threats to inform strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise SWOT snapshot of Ultralife for fast strategic alignment and quick stakeholder briefings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentrated Customer Base and Negotiating Power\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eA large share of Ultralife’s revenue is tied to a few defense contractors, with one customer accounting for over 20% of consolidated sales in 2024, leaving the company exposed to concentrated demand risk. This concentration gives major buyers significant negotiating power, often forcing price concessions and tighter contract terms that squeeze margins. A single contract delay or cancellation could cut quarterly revenue by double digits and harm cash flow, given limited customer diversification and fixed-cost structure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVolatility in Communications Systems Segment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Communications Systems segment shows lumpy revenue and sharp swings, notably a 36.2% year-over-year decline in Q1 2025, driven by timing of large government orders and deliveries. This timing risk makes consistent quarterly growth hard, as multiyear defense modernization budget cycles dictate award and shipment dates. Reliance on a few program awards raises predictability issues that can mask steady battery-product growth. If a major contract shifts, segment revenue can drop double-digits in a quarter.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMargin Compression from Product Mix Shifts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDespite revenue growth, Ultralife’s gross margin fell to about 25% in 2025, pressured by an unfavorable product mix and higher operating costs.\u003c\/p\u003e\n\u003cp\u003eThe company’s expanding share of lower-margin offerings and a pullback from high-margin medical and oil-and-gas sales can quickly erode profitability.\u003c\/p\u003e\n\u003cp\u003eScaling production while rebalancing sales toward richer-margin segments remains a persistent management challenge, with margin recovery hinging on SKU mix and cost control.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSmaller Scale Compared to Global Giants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCompared with giants like Panasonic (2024 revenue ¥7.1 trillion \/ US$48B) and Samsung SDI (2024 revenue ₩22.6 trillion \/ US$17B), Ultralife’s 2024 revenue of US$98.6M shows a much smaller scale, limiting economies of scale and raising unit costs.\u003c\/p\u003e\n\u003cp\u003eSmaller size weakens bargaining power with suppliers, increasing input cost sensitivity; higher per-unit R\u0026amp;D and capex burdens strain cash—Ultralife had negative free cash flow in FY2024, amplifying funding pressure.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003e2024 revenue: US$98.6M vs peers’ tens of billions\u003c\/li\u003e\n\u003cli\u003eHigher unit costs, weaker supplier leverage\u003c\/li\u003e\n\u003cli\u003eNegative FY2024 free cash flow raises capex\/R\u0026amp;D funding risk\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIncreased Debt and Financing Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe Electrochem acquisition was debt-funded, pushing Ultralife’s total long-term debt to about $210 million by Dec 31, 2025, and interest expense up ~85% YoY, squeezing 2025 net income and lowering free cash flow available for R\u0026amp;D and growth.\u003c\/p\u003e\n\u003cp\u003eUltralife remained inside covenants at year-end, but higher leverage in a 2025 average U.S. prime rate near 8% raises refinancing and liquidity risk if cash generation falters.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDebt level ≈ $210M (2025)\u003c\/li\u003e\n\u003cli\u003eInterest expense +85% YoY (2025)\u003c\/li\u003e\n\u003cli\u003eFree cash flow pressure—fewer funds for R\u0026amp;D\u003c\/li\u003e\n\u003cli\u003eCovenants met, but leverage increases refinancing risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh customer concentration, weak margins and $210M debt strain small-cap growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCustomer concentration (one \u0026gt;20% of sales in 2024) and lumpy Communications Systems orders drove volatile revenue; gross margin fell to ~25% in 2025 as mix shifted to lower-margin lines; 2024 revenue US$98.6M versus peers’ tens of billions; debt ≈ $210M (2025) with interest expense +85% YoY and negative FY2024 free cash flow, raising refinancing and R\u0026amp;D funding risk.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 Revenue\u003c\/td\u003e\n\u003ctd\u003eUS$98.6M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop customer share\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;20% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e~25% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLong-term debt\u003c\/td\u003e\n\u003ctd\u003e≈$210M (Dec 31, 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInterest expense change\u003c\/td\u003e\n\u003ctd\u003e+85% YoY (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFree cash flow\u003c\/td\u003e\n\u003ctd\u003eNegative FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003eUltralife SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality. The preview below is taken directly from the full SWOT report you'll get, and the file shown is not a sample but the real, editable analysis included in your download. Buy now to unlock the complete, detailed version immediately after checkout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752264806777,"sku":"ultralifecorporation-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/ultralifecorporation-swot-analysis.png?v=1772238836","url":"https:\/\/growthsharematrix.com\/products\/ultralifecorporation-swot-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}